XU Yu-yan, ZHU Liu-yan, SHAO Jie
徐钰艳, 朱柳燕, 邵洁
|  Michalus I,Rusińska A. Rare,genetically conditioned forms of rickets:Differential diagnosis and advances in diagnostics and treatment[J]. Clin Genet,2018,94(1) :103-114.
 Lambert AS,Linglart A. Hypocalcaemic and hypophosphatemic rickets[J]. Best Pract Res Clin Endocrinol Metab,2018,32(4):455-476.
 Robinson ME,AlQuorain H,Murshed M,et al. Mineralized tissues in hypophosphatemic rickets[J]. Pediatr Nephrol,2020,35(10):1843-1854.
 Goldsweig BK,Carpenter TO. Hypophosphatemic rickets:lessons from disrupted FGF23 control of phosphorus homeostasis[J]. Curr Osteoporos Rep,2015,13(2):88-97.
 Blaine J,Chonchol M,Levi M. Renal control of calcium,phosphate,and magnesium homeostasis[J]. Clin J Am Soc Nephrol,2015,10(7):1257-72.
 Kinoshita Y,Fukumoto S. X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases:prospect for new treatment[J]. Endocr Rev,2018,39(3):274-291.
 Christov M, Jüppner H. Phosphate homeostasis disorders[J]. Best Pract Res Clin Endocrinol Metab,2018,32(5):685-706.
 Bergwitz C,Miyamoto KI. Hereditary hypophosphatemic rickets with hypercalciuria:pathophysiology,clinical presentation,diagnosis and therapy[J]. Pflugers Arch,2019,471(1):149-163.
 Fuente R, Gil-Peña H, Claramunt-Taberner D,et al. X-linked hypophosphatemia and growth[J]. Rev Endocr Metab Disord,2017,18(1):107-115.
 Carpenter TO,Shaw NJ,Portale AA,et al.Rickets[J].Nat Rev Dis Primers,2017,3:17101.
 Menon LP,Weinstein RS.Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets:A review of the role of iron.[J].Bone,2020,131:115-137.
 Haffner D,Emma F,Eastwood DM,et al.Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia[J].Nat Rev Nephrol,2019,15(7):435-455.
 Rafaelsen S,Johansson S,Raeder H,et al.Hereditary hypophosphatemia in Norway:a retrospective population-based study of genotypes,phenotypes,and treatment complications[J].Eur J Endocrinol,2016,174(2):125-136.
 Gordon RJ,Levine MA.Burosumab treatment of children with X-linked hypophosphataemic rickets[J].Lancet,2019,393(10189):2364-2366.
 Bitzan M,Goodyer PR.Hypophosphatemic rickets[J].Pediatr Clin North Am,2019,66(1):179-207.
 Farrow EG,Yu X,Summers LJ,etal.Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice[J]. Proc Natl Acad Sci U S A,2011,108(46):1146-1155.
 Imel EA,Liu Z,Coffman M,et al. Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets[J]. J Bone Miner Res,2020,35(2):231-238
 Razali NN,Hwu TT,Thilakavathy K.Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets[J].J Pediatr Endocrinol Metab,2015,28(9-10):1009-1017.
 Oheim R,Zimmerman K,Maulding ND,et al. Human heterozygous ENPP1 deficiency is associated with early onset osteoporosis,a phenotype recapitulated in a mouse model of enpp1 deficiency[J]. J Bone Miner Res,2020,35(3):528-539.
 Kotwal A,Ferrer A,Kumar R,et al. Clinical and biochemical phenotypes in a family with ENPP1 mutations[J]. J Bone Miner Res,2020,35(4):662-670.
 Asch S,Sugarman JL. Epidermal nevus syndromes:New insights into whorls and swirls[J]. Pediatric Dermatol,2018,35:21-29.
 Avitan-Hersh E,Tatur S,Indelman M,et al. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23[J]. J Clin Endocrinol Metab,2014,99(1):132-136.
 Park PG,Park E,Hyun HS,et al. Cutaneous skeletal hypophosphatemia syndrome in association with a mosaic HRAS mutation[J]. Ann Clin Lab Sci,2018,48(5):665-669.
 Pal R,Dutta P,Mukherjee KK,et al. Acromegaly with hypophosphataemia:McCune-Albright syndrome[J]. BMJ Case Rep,2017:bcr2017221827.
 Obo T,Koriyama N,Tokito A,et al. Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23:a case report[J]. J Med Case Rep,2020,14(1):56.
 Rothenbuhler A,Schnabel D,Hogler W,et al.Diagnosis,treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)[J].Metabolism,2020,103s:153892.
 Chesher D,Oddy M,Darbar U,et al.Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations[J].J Inherit Metab Dis,2018,41(5):865-876.
 Vega RA,Opalak C,Harshbarger RJ,et al.Hypophosphatemic rickets and craniosynostosis:a multicenter case series[J].J Neurosurg Pediatr,2016,17(6):694-700.
 Rothenbuhler A,Fadel N,Debza Y,et al.High incidence of cranial synostosis and chiari I malformation in children with X-Linked hypophosphatemic rickets (XLHR)[J].J Bone Miner Res,2019,34(3):490-496.
 Brachet C,Mansbach AL,Clerckx A,et al.Hearing loss is part of the clinical picture of ENPP1 loss of function mutation[J].Horm Res Paediatr,2014,81(1):63-66.
 Lempicki M,Rothenbuhler A,Merzoug V,et al.Magnetic resonance imaging features as surrogate markers of X-Linked hypophosphatemic rickets activity.[J].Horm Res Paediatr,2017,87(4):244-253.
 Keskin M,Savas-Erdeve S,Sagsak E,et al.Risk factors affecting the development of nephrocalcinosis,the most common complication of hypophosphatemic rickets[J].J Pediatr Endocrinol Metab,2015,28(11-12):1333-1337.
 Insogna KL,Briot K,Imel EA,et al.A Randomized,double-blind,placebo-controlled,phase 3 trial evaluating the efficacy of burosumab,an anti-FGF23 antibody,in adults with X-Linked Hypophosphatemia:Week 24 primary analysis[J].J Bone Miner Res,2018,33(8):1383-1393.
 Lamb YN.Burosumab:First global approval[J].Drugs,2018,78(6):707-714.
 Kapelari K,Kohle J,Kotzot D,et al. Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets[J].J Clinton Endocrinol Metab,2015,100(9):3388-3392.
 Meyerhoff N,Haffner D,Staude H,et al.Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets[J].Pediatr Nephrol,2018,33(3):447-456.
 Sharkey MS,Grunseich K,Carpenter TO.Contemporary medical and surgical management of X-linked hypophosphatemic rickets[J].J Am Acad Orthop Surg,2015,23(7):433-442.
|||XIANG Wei. Early prevention of dyslipidemia in children and adolescents as well as cardiovascular health in adulthood [J]. Chinese Journal of Child Health Care, 2023, 31(7): 697-702.|
|||WU Ting, LI Fei. Adverse factors in early life and the development and prevention of chronic diseases [J]. Chinese Journal of Child Health Care, 2023, 31(7): 703-706.|
|||LIU Haodong, LI Cheng, ZHAO Min, XI Bo. Association of abdominal obesity and pre-abdominal obesity with hyperuricemia in children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 707-712.|
|||LIU Min, ZHANG Qian, YANG Ting, CHEN Jie, CHEN Li, DAI Ying, JIA Feiyong, WU Lijie, HAO Yan, LI Ling, ZHANG Jie, KE Xiaoyan, YI Mingji, HONG Qi, CHEN Jinjin, FANG Shuanfeng, WANG Yichao, WANG Qi, JIN Chunhua, LI Tingyu. Multi-center survey on serum folic acid in preschool children in China [J]. Chinese Journal of Child Health Care, 2023, 31(7): 713-717.|
|||HUO Yanyan, LIU Zhongling, MA Ling, WU Dan, WANG Xiulian, QIU Xiaoyan, DOU Jiaying, REN Yuqian, LI Yicheng, HONG Xia, CHEN Jinjin. Status quo and risk factors for different body proportions of children under 2 years old in the real world [J]. Chinese Journal of Child Health Care, 2023, 31(7): 718-723.|
|||LIU Huijuan, SONG Zhixiao, GAO Nannan, ZHANG Li, SUN Jin, QIAO Xiuyun, KE Jiamei, LI Yan. Status quo and related factors of Chinese vocabulary and grammar development in children aged 2 to 6 years [J]. Chinese Journal of Child Health Care, 2023, 31(7): 724-730.|
|||LI Rong, LI Nian, WU Dandan, HUANG Rong, CHEN Yinhua. Effect of methylphenidate hydrochloride prolonged-release tablets on the growth of children with attention deficit hyperactivity disorder [J]. Chinese Journal of Child Health Care, 2023, 31(7): 731-735.|
|||ZHANG Chao. Application of early start Denver model in the rehabilitation of children with autism spectrum disorder of different conditions [J]. Chinese Journal of Child Health Care, 2023, 31(7): 736-740.|
|||YANG Yuru, WANG Hong, XU Shuhong, CAO Yanmei, MENG Xian, GE Dongmei. Association between bone development and vitamin K in children aged 0 to 14 years [J]. Chinese Journal of Child Health Care, 2023, 31(7): 746-750.|
|||YE Zhixu, YU Fuxun. Research progress of gut microbiota and respiratory virus infection in children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 766-769.|
|||LI Weiwei, ZHANG Dandan, LIU Xiaoming, CHEN Jiao, XIA Lu. Application of long-term management mode based on Internet technology in children with intractable epilepsy [J]. Chinese Journal of Child Health Care, 2023, 31(7): 781-784.|
|||ZHU Lijun, LI Biaozhang, ZHOU Jiawen, WU Baixin, LI Weidong. Disease burden of low body weight in children under 5 years old in China from 1990 to 2019 [J]. Chinese Journal of Child Health Care, 2023, 31(7): 790-793.|
|||CAO Yachuan, DOU Jijuan, MA Yaping, REN Jindong, CHEN Xinyan. Correlation of lipid metabolism with left ventricular hypertrophy and left ventricular remodeling in obese children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 809-812.|
|||LI Xiuhong. Early identification of Chinese developmental dyslexia should be valued [J]. Chinese Journal of Child Health Care, 2023, 31(6): 586-589.|
|||WANG Hongan, YU Dongchuan, LIU Fulin, CHI Xia. Feasibility study on rapid screening of learning disabilities by number cancellation test in combination with machine learning algorithm [J]. Chinese Journal of Child Health Care, 2023, 31(6): 595-600.|